Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGattaca Regulatory News (GATC)

Share Price Information for Gattaca (GATC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 93.00
Bid: 92.00
Ask: 94.00
Change: 0.00 (0.00%)
Spread: 2.00 (2.174%)
Open: 93.00
High: 93.00
Low: 93.00
Prev. Close: 93.00
GATC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full Year Trading Update and Notice of Results

17 Jul 2020 07:00

RNS Number : 2755T
Gattaca PLC
17 July 2020
 

17 July 2020

 

Gattaca plc

("Gattaca", "the Group" or "the Company")

 

Full Year Trading Update and Notice of Results

 

 

Gattaca plc (LSE-AIM: GATC), the UK's leading specialist Engineering and Technology recruitment business, today provides the following trading update for the year ending 31 July 2020.

 

Summary

 

Trading during April, May and June 2020, reflecting the impact of the UK Government measures due to COVID-19, has been 41% below last year

Significant action taken to improve liquidity; the Group is now in a net cash position with strong working capital and liquidity. New covenants agreed with principal lender, HSBC, through to July 2021

The Group-wide Improvement Plan has been accelerated, with particular focus on improving sales impact and client service, and on cost reduction

 

Performance and trading

 

Whilst the COVID-19 pandemic has impacted Group performance, trading over the period has been stronger than the Board's initial expectations following the imposition of the UK-wide lock-down. Trading during April, May and June 2020 has been 41% below last year (contract 36% and perm 52% lower).

 

Overall, continuing operations' Net Fee Income (NFI) for the year ending 31 July 2020 is expected to be in the region of £54m (FY 2019: £69m), approximately 22% below prior year. Previous consensus forecasts were £64m. The majority of the shortfall is in UK NFI.

 

The Group's international operations have performed better than expected, having implemented cost reductions over the last few months. Our China business is now operationally closed.

 

During this period, the health and safety of our colleagues has been our key priority. All staff are working remotely and were fully operational within a few days of the lock-down announcement and we continued to win new business both in contract and permanent recruitment. In the UK, we have utilised the Government furlough scheme and the Board, executive management and all staff have taken a temporary 20% salary reduction for a period, with the staff having now been returned to full pay.

 

As we see some encouraging signs of increased activity, we are beginning to bring staff back from furlough and have reopened our offices following staff engagement and reconfiguration of spaces to be COVID-compliant.

 

Net cash and financing

 

The Group is now in a net cash position. At 30 June 2020 we held net cash of £23m (31 January: net debt £(3)m; 31 July 2019: net debt £(25)m). Non-recourse invoice financing as at 30 June 2020 (not included in reported net debt) was £22m (31 July 2019: nil).

 

Our strong working capital management continues, including specific actions to better align our contractor payment terms to normal practice in other industries and organisations. This is a phased programme and we expect further benefits over the next 18 months. The move of contractor payment terms has contributed approximately £2m to date. 

 

In addition, reduced trading levels of our contract business has led to a release of working capital and our cash flow has also benefitted from the deferral of an HMRC payment amounting to £10m, which is not due until 31 March 2021.

 

These actions have enabled us to provide support to our customers and as a consequence we expect to see a slight increase in our days sales outstanding number. 

 

Our bank, HSBC, continues to be supportive and new covenants for our Revolving Credit Facility ("RCF") have been agreed through to 31 July 2021.

 

As of 30 June 2020, available liquidity (Group cash balances plus total additional funds which can be further drawn under our invoice financing facilities) stood at £59m. The Group's total invoice financing facility limit is £75m.

 

Following our previously agreed repayment schedule, the RCF balance will reduce to £8m at 31 July 2020, and to £5m by 31 October 2020. The RCF is the only element of our financing that includes covenants and our strong liquidity enables us to repay this and eliminate covenant requirements entirely should we choose to do so.

 

Improvement Plan and cost reduction

 

During the period, we continued to implement our Group-wide Improvement Plan, and we have accelerated a number of planned changes. This has allowed us to drive efficiencies through our operations, including increased digitisation, changes to business terms, improvements to core processes, and a restructuring to enhance our Solutions service. We have also implemented a more focused approach to how we target industry sectors and are aligning our talent more closely to our operating model with respect to sales and client delivery. The Group has taken action to reduce costs in respect of its international operations and all of these changes are already having a positive impact.

 

Through the combination of these actions, we are targeting annualised cost savings in excess of £3m starting around the end of H1 2021. Consequently, we have commenced a consultation process with staff.

 

Notice of full year results

 

The Group expects to announce its full year results for the 12 months to 31 July 2020 on Wednesday 4 November 2020.

 

Kevin Freeguard, Chief Executive Officer said:

 

"The COVID-19 pandemic has created unprecedented challenges for Gattaca and for UK industry in general. However, I am pleased with the way the business has responded and the resilience we have shown. During the period, we have taken a number of measures to strengthen the business, including the acceleration of the Group-wide Improvement Plan, and the outstanding response from our staff to the challenges arising from COVID-19 has enabled Gattaca to perform ahead of our expectations in these difficult circumstances. On behalf of the Board, I would like to express my thanks to the staff for their dedication through these extraordinarily difficult national times.

 

"The balance sheet has continued to improve beyond our normal cycles, increasing our financial stability, and the significant liquidity will allow us to aggressively pursue growth opportunities to take advantage of the inevitable recovery in our markets. In particular, we are well aligned with the anticipated UK Government investment targets such as Infrastructure and other STEM-driven sectors where Gattaca has a significant track record and capability.

 

"Gattaca is a resilient business and I am confident that our performance through this crisis, together with the acceleration of the Improvement Plan, will enable Gattaca to emerge stronger as the recovery takes shape."

 

 

The information communicated in this announcement contains inside information for the purposes of Article. 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

For further information, please contact:

Gattaca plc

+44 (0) 1489 898989

Kevin Freeguard, Chief Executive Officer

Salar Farzad, Chief Financial Officer

 

 

Liberum Capital Limited (Nomad and Broker)

+44 (0) 20 3100 2000

Bidhi Bhoma

Robert Morton

Euan Brown

 

 

 

Citigate Dewe Rogerson

+44 (0) 20 7638 9571

Nick Hayns

Louise Mason-Rutherford

Lucy Eyles

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTDZGMNVVVGGZM
Date   Source Headline
20th Feb 20194:40 pmRNSSecond Price Monitoring Extn
20th Feb 20194:35 pmRNSPrice Monitoring Extension
7th Feb 20197:00 amRNSTrading Update for 6 months ended 31 January 2019
20th Dec 20184:56 pmRNSDirector/PDMR Shareholding
12th Dec 20181:21 pmRNSStandard form for notification of major holdings
7th Dec 20189:58 amRNSStandard form for notification of major holdings
5th Dec 20183:21 pmRNSResult of AGM
13th Nov 20187:00 amRNSNotice of AGM
8th Nov 20187:00 amRNSDirectorate Change
8th Nov 20187:00 amRNSPreliminary Results
25th Oct 20184:40 pmRNSSecond Price Monitoring Extn
25th Oct 20184:35 pmRNSPrice Monitoring Extension
8th Oct 201812:07 pmRNSSecond Price Monitoring Extn
8th Oct 201812:02 pmRNSPrice Monitoring Extension
3rd Oct 20189:41 amRNSAdmission of Shares and Block Admission
1st Oct 201811:39 amRNSBlock Listing Six Monthly Return
19th Sep 20187:00 amRNSAppointment of Chief Executive Officer
4th Sep 20187:00 amRNSUpdate on international operations
2nd Aug 20187:00 amRNSTrading Update for 12 months ended 31 July 2018
31st May 20183:09 pmRNSStandard form for notification of major holdings
29th May 20185:29 pmRNSStandard form for notification of major holdings
14th May 20181:50 pmRNSStandard form for notification of major holdings
14th May 20187:00 amRNSStandard form for notification of major holdings
9th May 20187:00 amRNSDirector/PDMR Shareholding
1st May 20187:00 amRNSStandard form for notification of major holdings
1st May 20187:00 amRNSStandard form for notification of major holdings
19th Apr 20187:00 amRNSNon-Executive Director Changes
19th Apr 20187:00 amRNSInterim Results
23rd Feb 20187:00 amRNSStandard form for notification of major holdings
23rd Feb 20187:00 amRNSStandard form for notification of major holdings
15th Feb 20187:00 amRNSTr-1: Notification Of Major Interest In Shares
7th Feb 20182:30 pmRNSDirectorate Change
7th Feb 20182:30 pmRNSTrading Update
17th Jan 20187:00 amRNSStatement re Share Price Movement
16th Jan 201811:53 amRNSDirector / PDMR Shareholding
8th Jan 201812:02 pmRNSPrice Monitoring Extension
14th Dec 20171:46 pmRNSDirector/PDMR Shareholding
13th Dec 20174:58 pmRNSDirector/PDMR Shareholding - Amendment
12th Dec 20177:00 amRNSDirector/PDMR Shareholding
11th Dec 20172:14 pmRNSDirector/PDMR Shareholding
6th Dec 201710:38 amRNSResult of Annual General Meeting
4th Dec 20174:25 pmRNSDirector/PDMR Shareholding
4th Dec 201711:40 amRNSDirector/PDMR Shareholding
15th Nov 20177:00 amRNSNotice of Annual General Meeting
9th Nov 20177:00 amRNSPreliminary Results
20th Sep 20175:57 pmRNSTr-1: Notification Of Major Interest In Shares
3rd Aug 20177:00 amRNSTrading Update
14th Jul 20174:40 pmRNSSecond Price Monitoring Extn
14th Jul 20174:35 pmRNSPrice Monitoring Extension
23rd Jun 20178:51 amRNSDirector Resignation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.